» Articles » PMID: 31936706

A Single Dose of Dendrimer BT Peptide Vaccine Partially Protects Pigs Against Foot-and-Mouth Disease Virus Infection

Overview
Date 2020 Jan 16
PMID 31936706
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Foot-and-mouth disease virus (FMDV) causes a highly contagious disease of cloven-hoofed animals whose control relies on efficient vaccination. We have reported that dendrimer peptide BT, with two copies of FMDV B-cell epitope VP1 (136-154) linked through maleimide units to T-cell epitope 3A (21-35)], elicits potent B- and T-cell specific responses and confers solid protection in pigs to type-O FMDV challenge after two doses of peptide. Herein we now show that BT evokes specific protective immune responses after administration of a single dose of either 2 or 0.5 mg of peptide. High titers of ELISA and neutralizing antibodies against FMDV were detectable at day 15 post-immunization. Likewise, activated T cells and induced IFN-γ response to in vitro recall with FMDV peptides were also detected by the same day. Further, in 70% of BT-vaccinated pigs, full protection-no clinical signs of disease-was observed upon virus challenge at day 25 post-immunization. These results strengthen the potential of BT as a safe, cost-effective candidate vaccine conferring adequate protection against FMDV with a single dose. The finding is particularly relevant to emergency scenarios permitting only a single shot immunization.

Citing Articles

Foot-and-mouth disease in Asia.

Rahman M, Zereen F, Rana M, Hossain M, Shimada M, Saha S Virus Res. 2024; 351:199514.

PMID: 39689813 PMC: 11770323. DOI: 10.1016/j.virusres.2024.199514.


Evaluation of vaccine efficacy with 2B/T epitope conjugated porcine IgG-Fc recombinants against foot-and-mouth disease virus.

Song B, Lee G, Kang S, Tark D J Vet Med Sci. 2024; 86(9):999-1007.

PMID: 39069487 PMC: 11422696. DOI: 10.1292/jvms.23-0480.


A ferritin-based nanoparticle displaying a neutralizing epitope for foot-and-mouth disease virus (FMDV) confers partial protection in guinea pigs.

Lu B, Ru Y, Hao R, Yang Y, Liu H, Li Y BMC Vet Res. 2024; 20(1):301.

PMID: 38971791 PMC: 11227194. DOI: 10.1186/s12917-024-04159-9.


Display of porcine epidemic diarrhea virus spike protein B-cell linear epitope on Lactobacillus mucosae G01 S-layer surface induce a robust immunogenicity in mice.

Zhang B, Gou H, Shen H, Zhang C, Liu Z, Wuri N Microb Cell Fact. 2024; 23(1):142.

PMID: 38773481 PMC: 11110301. DOI: 10.1186/s12934-024-02409-x.


Foot-and-mouth disease virus VP1 degrades YTHDF2 through autophagy to regulate IRF3 activity for viral replication.

Liu H, Xue Q, Yang F, Cao W, Liu P, Liu X Autophagy. 2024; 20(7):1597-1615.

PMID: 38516932 PMC: 11210904. DOI: 10.1080/15548627.2024.2330105.


References
1.
Taboga O, Tami C, Carrillo E, Nunez J, Rodriguez A, Saiz J . A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J Virol. 1997; 71(4):2606-14. PMC: 191381. DOI: 10.1128/JVI.71.4.2606-2614.1997. View

2.
Blanco E, McCullough K, Summerfield A, Fiorini J, Andreu D, Chiva C . Interspecies major histocompatibility complex-restricted Th cell epitope on foot-and-mouth disease virus capsid protein VP4. J Virol. 2000; 74(10):4902-7. PMC: 112017. DOI: 10.1128/jvi.74.10.4902-4907.2000. View

3.
Garcia-Arriaza J, Manrubia S, Toja M, Domingo E, Escarmis C . Evolutionary transition toward defective RNAs that are infectious by complementation. J Virol. 2004; 78(21):11678-85. PMC: 523252. DOI: 10.1128/JVI.78.21.11678-11685.2004. View

4.
Garcia-Briones M, Blanco E, Chiva C, Andreu D, Ley V, Sobrino F . Immunogenicity and T cell recognition in swine of foot-and-mouth disease virus polymerase 3D. Virology. 2004; 322(2):264-75. DOI: 10.1016/j.virol.2004.01.027. View

5.
Sumption K, Rweyemamu M, Wint W . Incidence and distribution of foot-and-mouth disease in Asia, Africa and South America; combining expert opinion, official disease information and livestock populations to assist risk assessment. Transbound Emerg Dis. 2008; 55(1):5-13. DOI: 10.1111/j.1865-1682.2007.01017.x. View